HEADER ONCOPROTEIN 22-AUG-06 2DWZ TITLE STRUCTURE OF THE ONCOPROTEIN GANKYRIN IN COMPLEX WITH S6 ATPASE OF THE TITLE 2 26S PROTEASOME COMPND MOL_ID: 1; COMPND 2 MOLECULE: 26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 10; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: 26S PROTEASOME REGULATORY SUBUNIT P28, GANKYRIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: 26S PROTEASE REGULATORY SUBUNIT 6B; COMPND 8 CHAIN: B, D; COMPND 9 FRAGMENT: C-TERMINAL DOMAIN; COMPND 10 SYNONYM: TAT-BINDING PROTEIN-7, TBP-7; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PETDUET1 VECTOR; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 10 ORGANISM_COMMON: NORWAY RAT; SOURCE 11 ORGANISM_TAXID: 10116; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 EXPRESSION_SYSTEM_VECTOR_TYPE: PETDUET1 VETOR KEYWDS ANKYRIN REPEATS, A-HELICAL DOMAIN, STRUCTURAL GENOMICS, NPPSFA, KEYWDS 2 NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, KEYWDS 3 RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI, ONCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.PADMANABHAN,S.YOKOYAMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 2 INITIATIVE (RSGI) REVDAT 3 13-MAR-24 2DWZ 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DWZ 1 VERSN REVDAT 1 28-AUG-07 2DWZ 0 JRNL AUTH Y.NAKAMURA,K.NAKANO,T.UMEHARA,A.TANAKA,B.PADMANABHAN, JRNL AUTH 2 S.YOKOYAMA JRNL TITL STRUCTURE OF THE ONCOPROTEIN GANKYRIN IN COMPLEX WITH S6 JRNL TITL 2 ATPASE OF THE 26S PROTEASOME JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.2 REMARK 3 NUMBER OF REFLECTIONS : 23168 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2268 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 346 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4616 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.830 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DWZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000025946. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-05 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24356 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.31300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.99550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.59550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.15950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 83.59550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.99550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.15950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 GLY A 3 REMARK 465 SER A 230 REMARK 465 MET A 231 REMARK 465 LYS B 409 REMARK 465 ASP B 410 REMARK 465 GLU B 411 REMARK 465 GLN B 412 REMARK 465 GLU B 413 REMARK 465 HIS B 414 REMARK 465 GLU B 415 REMARK 465 PHE B 416 REMARK 465 TYR B 417 REMARK 465 LYS B 418 REMARK 465 MET C 1 REMARK 465 GLU C 2 REMARK 465 GLY C 3 REMARK 465 SER C 230 REMARK 465 MET C 231 REMARK 465 LYS D 409 REMARK 465 ASP D 410 REMARK 465 GLU D 411 REMARK 465 GLN D 412 REMARK 465 GLU D 413 REMARK 465 HIS D 414 REMARK 465 GLU D 415 REMARK 465 PHE D 416 REMARK 465 TYR D 417 REMARK 465 LYS D 418 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 87.38 -162.98 REMARK 500 ASP A 37 -164.12 -103.05 REMARK 500 ARG A 85 71.80 -103.64 REMARK 500 HIS A 137 -4.21 -57.96 REMARK 500 ASN A 151 69.18 -69.83 REMARK 500 TYR A 161 32.09 -97.98 REMARK 500 GLU A 205 15.20 58.49 REMARK 500 ASN C 103 -158.26 -95.49 REMARK 500 HIS C 137 0.15 -62.78 REMARK 500 TYR C 161 30.55 -98.54 REMARK 500 LYS C 213 -98.27 -66.93 REMARK 500 GLU C 228 67.64 70.42 REMARK 500 ARG D 338 -38.47 -32.34 REMARK 500 ILE D 407 95.39 -63.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPE A 2241 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: MMK001001374.3 RELATED DB: TARGETDB DBREF 2DWZ A 1 231 UNP Q9Z2X2 PSD10_MOUSE 1 231 DBREF 2DWZ C 1 231 UNP Q9Z2X2 PSD10_MOUSE 1 231 DBREF 2DWZ B 337 418 UNP Q63570 PRS6B_RAT 337 418 DBREF 2DWZ D 337 418 UNP Q63570 PRS6B_RAT 337 418 SEQADV 2DWZ MET B 336 UNP Q63570 INITIATING METHIONINE SEQADV 2DWZ MET D 336 UNP Q63570 INITIATING METHIONINE SEQRES 1 A 231 MET GLU GLY CYS VAL SER ASN ILE MET ILE CYS ASN LEU SEQRES 2 A 231 ALA TYR SER GLY LYS LEU ASP GLU LEU LYS GLU ARG ILE SEQRES 3 A 231 LEU ALA ASP LYS SER LEU ALA THR ARG THR ASP GLN ASP SEQRES 4 A 231 SER ARG THR ALA LEU HIS TRP ALA CYS SER ALA GLY HIS SEQRES 5 A 231 THR GLU ILE VAL GLU PHE LEU LEU GLN LEU GLY VAL PRO SEQRES 6 A 231 VAL ASN ASP LYS ASP ASP ALA GLY TRP SER PRO LEU HIS SEQRES 7 A 231 ILE ALA ALA SER ALA GLY ARG ASP GLU ILE VAL LYS ALA SEQRES 8 A 231 LEU LEU VAL LYS GLY ALA HIS VAL ASN ALA VAL ASN GLN SEQRES 9 A 231 ASN GLY CYS THR PRO LEU HIS TYR ALA ALA SER LYS ASN SEQRES 10 A 231 ARG HIS GLU ILE ALA VAL MET LEU LEU GLU GLY GLY ALA SEQRES 11 A 231 ASN PRO ASP ALA LYS ASP HIS TYR ASP ALA THR ALA MET SEQRES 12 A 231 HIS ARG ALA ALA ALA LYS GLY ASN LEU LYS MET VAL HIS SEQRES 13 A 231 ILE LEU LEU PHE TYR LYS ALA SER THR ASN ILE GLN ASP SEQRES 14 A 231 THR GLU GLY ASN THR PRO LEU HIS LEU ALA CYS ASP GLU SEQRES 15 A 231 GLU ARG VAL GLU GLU ALA LYS PHE LEU VAL THR GLN GLY SEQRES 16 A 231 ALA SER ILE TYR ILE GLU ASN LYS GLU GLU LYS THR PRO SEQRES 17 A 231 LEU GLN VAL ALA LYS GLY GLY LEU GLY LEU ILE LEU LYS SEQRES 18 A 231 ARG LEU ALA GLU GLY GLU GLU ALA SER MET SEQRES 1 B 83 MET ASP ARG ARG GLN LYS ARG LEU ILE PHE SER THR ILE SEQRES 2 B 83 THR SER LYS MET ASN LEU SER GLU GLU VAL ASP LEU GLU SEQRES 3 B 83 ASP TYR VAL ALA ARG PRO ASP LYS ILE SER GLY ALA ASP SEQRES 4 B 83 ILE ASN SER ILE CYS GLN GLU SER GLY MET LEU ALA VAL SEQRES 5 B 83 ARG GLU ASN ARG TYR ILE VAL LEU ALA LYS ASP PHE GLU SEQRES 6 B 83 LYS ALA TYR LYS THR VAL ILE LYS LYS ASP GLU GLN GLU SEQRES 7 B 83 HIS GLU PHE TYR LYS SEQRES 1 C 231 MET GLU GLY CYS VAL SER ASN ILE MET ILE CYS ASN LEU SEQRES 2 C 231 ALA TYR SER GLY LYS LEU ASP GLU LEU LYS GLU ARG ILE SEQRES 3 C 231 LEU ALA ASP LYS SER LEU ALA THR ARG THR ASP GLN ASP SEQRES 4 C 231 SER ARG THR ALA LEU HIS TRP ALA CYS SER ALA GLY HIS SEQRES 5 C 231 THR GLU ILE VAL GLU PHE LEU LEU GLN LEU GLY VAL PRO SEQRES 6 C 231 VAL ASN ASP LYS ASP ASP ALA GLY TRP SER PRO LEU HIS SEQRES 7 C 231 ILE ALA ALA SER ALA GLY ARG ASP GLU ILE VAL LYS ALA SEQRES 8 C 231 LEU LEU VAL LYS GLY ALA HIS VAL ASN ALA VAL ASN GLN SEQRES 9 C 231 ASN GLY CYS THR PRO LEU HIS TYR ALA ALA SER LYS ASN SEQRES 10 C 231 ARG HIS GLU ILE ALA VAL MET LEU LEU GLU GLY GLY ALA SEQRES 11 C 231 ASN PRO ASP ALA LYS ASP HIS TYR ASP ALA THR ALA MET SEQRES 12 C 231 HIS ARG ALA ALA ALA LYS GLY ASN LEU LYS MET VAL HIS SEQRES 13 C 231 ILE LEU LEU PHE TYR LYS ALA SER THR ASN ILE GLN ASP SEQRES 14 C 231 THR GLU GLY ASN THR PRO LEU HIS LEU ALA CYS ASP GLU SEQRES 15 C 231 GLU ARG VAL GLU GLU ALA LYS PHE LEU VAL THR GLN GLY SEQRES 16 C 231 ALA SER ILE TYR ILE GLU ASN LYS GLU GLU LYS THR PRO SEQRES 17 C 231 LEU GLN VAL ALA LYS GLY GLY LEU GLY LEU ILE LEU LYS SEQRES 18 C 231 ARG LEU ALA GLU GLY GLU GLU ALA SER MET SEQRES 1 D 83 MET ASP ARG ARG GLN LYS ARG LEU ILE PHE SER THR ILE SEQRES 2 D 83 THR SER LYS MET ASN LEU SER GLU GLU VAL ASP LEU GLU SEQRES 3 D 83 ASP TYR VAL ALA ARG PRO ASP LYS ILE SER GLY ALA ASP SEQRES 4 D 83 ILE ASN SER ILE CYS GLN GLU SER GLY MET LEU ALA VAL SEQRES 5 D 83 ARG GLU ASN ARG TYR ILE VAL LEU ALA LYS ASP PHE GLU SEQRES 6 D 83 LYS ALA TYR LYS THR VAL ILE LYS LYS ASP GLU GLN GLU SEQRES 7 D 83 HIS GLU PHE TYR LYS HET EPE A2241 15 HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN EPE HEPES FORMUL 5 EPE C8 H18 N2 O4 S FORMUL 6 HOH *233(H2 O) HELIX 1 1 ILE A 8 SER A 16 1 9 HELIX 2 2 LYS A 18 ASP A 29 1 12 HELIX 3 3 LYS A 30 THR A 34 5 5 HELIX 4 4 THR A 42 GLY A 51 1 10 HELIX 5 5 HIS A 52 LEU A 62 1 11 HELIX 6 6 SER A 75 ALA A 83 1 9 HELIX 7 7 ARG A 85 LYS A 95 1 11 HELIX 8 8 THR A 108 LYS A 116 1 9 HELIX 9 9 ARG A 118 GLY A 128 1 11 HELIX 10 10 THR A 141 GLY A 150 1 10 HELIX 11 11 ASN A 151 TYR A 161 1 11 HELIX 12 12 THR A 174 GLU A 182 1 9 HELIX 13 13 ARG A 184 GLN A 194 1 11 HELIX 14 14 THR A 207 ALA A 212 1 6 HELIX 15 15 GLY A 215 ALA A 229 1 15 HELIX 16 16 ASP B 337 SER B 350 1 14 HELIX 17 17 LEU B 360 ALA B 365 1 6 HELIX 18 18 SER B 371 ARG B 388 1 18 HELIX 19 19 LEU B 395 ILE B 407 1 13 HELIX 20 20 ILE C 8 GLY C 17 1 10 HELIX 21 21 LYS C 18 ASP C 29 1 12 HELIX 22 22 LYS C 30 ARG C 35 5 6 HELIX 23 23 THR C 42 ALA C 50 1 9 HELIX 24 24 HIS C 52 LEU C 62 1 11 HELIX 25 25 SER C 75 ALA C 83 1 9 HELIX 26 26 ARG C 85 LYS C 95 1 11 HELIX 27 27 THR C 108 LYS C 116 1 9 HELIX 28 28 ARG C 118 GLY C 128 1 11 HELIX 29 29 THR C 141 LYS C 149 1 9 HELIX 30 30 ASN C 151 TYR C 161 1 11 HELIX 31 31 THR C 174 GLU C 182 1 9 HELIX 32 32 ARG C 184 GLN C 194 1 11 HELIX 33 33 THR C 207 ALA C 212 1 6 HELIX 34 34 GLY C 215 GLU C 225 1 11 HELIX 35 35 GLY C 226 GLU C 228 5 3 HELIX 36 36 ASP D 337 LYS D 351 1 15 HELIX 37 37 LEU D 360 ALA D 365 1 6 HELIX 38 38 SER D 371 GLU D 389 1 19 HELIX 39 39 LEU D 395 ILE D 407 1 13 SITE 1 AC1 4 GLY A 150 ASN A 151 LEU A 152 LYS A 153 CRYST1 41.991 92.319 167.191 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023815 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010832 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005981 0.00000